Navigation Links
MDS Pharma Services Names Rudy Howard Chief Financial Officer
Date:1/7/2009

KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced the appointment of Rudy Howard as Senior Vice-President and Chief Financial Officer.

Mr. Howard has extensive experience as a senior financial executive in the pharmaceutical and contract research organization (CRO) industry sectors, including six years as CFO at Pharmaceutical Product Development, Inc. He joins MDS Pharma Services from his private consulting practice where he offered business and financial consulting services, including merger and acquisition services, for clients across a variety of industries, including pharmaceutical and biotechnology.

"We are delighted to add someone with Rudy's breadth and depth of skills and expertise to our leadership team at MDS Pharma Services," said MDS Pharma Services President David Spaight. "His impressive portfolio of financial, business development and change management capabilities in the pharmaceutical and contract research industries makes him an excellent choice to lead the MDS Pharma Services finance organization at this time."

Before founding his consulting practice, Mr. Howard was CFO at Peopleclick Inc., a human resources software-development company. Previously, he was a Partner at PricewaterhouseCoopers, where his specialization included financial services, high technology, pharmaceuticals and manufacturing. He began his career in public accounting with Deloitte and Touche LLP.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on-time. We offer a full spectrum of resources to meet the drug-discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,000 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Pharma Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NABP Expanding Computer-Based Test Delivery to Include Foreign Pharmacy Graduate Equivalency Examination(R)
2. MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009
3. M Resort, Spa and Casino to Include On-Property Pharmacy
4. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimers Patents and Patent Applications
5. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
6. Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
7. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
8. Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott
9. Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
10. Akrimax Pharmaceuticals Announces Manufacturing Partnership
11. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: